
pmid: 3999148
pmc: PMC2561847
Ranitidine hydrochloride (Zantac) is a recently released H(2)-receptor antagonist that is stated not to cause significant increases in serum gastrin. The case described herein demonstrates that this is not always true. Zantac produced significant acute hypergastrinemia, which was sustained for several days after the discontinuation of the drug.
Time Factors, Gastrins, Humans, Female, Middle Aged, Ranitidine
Time Factors, Gastrins, Humans, Female, Middle Aged, Ranitidine
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 3 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
